Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Construction of Diagnostic Model for Vaginal Laxity

NCT07933120 is registered in ClinicalTrials.gov with Peking University People's Hospital as lead sponsor.

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, 14-day trial. Card required. Your first charge is when the trial ends. See pricing

Get the NCT07933120 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Follow this trial by email

Registry record

As filed in ClinicalTrials.gov.

Title
Construction of Diagnostic Model for Vaginal Laxity
Lead sponsor
Peking University People's Hospital
Phase
Observational
Overall status
Not yet recruiting
Start date
November 15, 2026
Completion date
December 31, 2028
Enrollment
500 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

vaginal laxity

Arms

As registered; 3 arms.

  • Group 1: Pelvic floor muscle training Pelvic floor muscle training

    For patients whose vaginas can accommodate more than two fingers, if they undergo pelvic floor muscle exercises, they will be assigned to Group 1.

  • Group 2: physical therapy Physical treatment

    For patients whose vaginas can accommodate more than two fingers, if they receive physical therapy, including laser, radiofrequency, and biofeedback, they will be classified into Group 2.

  • Group 3: Surgery surgery

    For patients whose vaginas can accommodate more than two fingers, if they receive surgeries, they will be classified into Group 3.

Primary endpoints

Registered primary outcome measures; 1 primary.

  • Construction of diagnostic model for vaginal laxity From enrollment to the end of treatment at 12 months

    Integrating multi-model indicators to construct gold standard diagnostic model for vaginal laxity, including age (year), weight (kg), height (m), gravidity, parity, vaginal tactile imaging, pelvic floor ultrasound, POP-Q points, modified oxford muscle strength, female sex function index (FSFI), International Consultation on Incontinence Questionnaire (ICIQ), Pelvic Floor Distress Inventory-20(PFDI-20) and Overactive bladder symptom score (OABSS)

Lead sponsor's other trials

Peking University People's Hospital, most recent start first.